 |
_______________________________________________________________ Angio-Proteomie, a globle supplier of biomedical research reagents, is dedicated in serving the Biomedical Research Communities, with top quality reagents, including antibodies, recombinant proteins, recombinant adenoviruses, and primary endothelial cells. _______________________________________________________________ Featured Products Functional antibodies Agonistic antibodis: VEGFR1 and VEGFR2 Antagonistic antibodies: VEGFR1, VEGFR2, VEGFR3, PECAM1 (CD31) and endoglin (CD105) Neutralizing antibodies: VEGF-A, VEGF-C, and PlGF Mouse endothelial,inflammatory cells and CDs markers (IHC on paraffin sections) Endothelial markers: CD31, CD34, VEGFR2, and CD105 et. al. Mouse CDs markers: CD3, CD4, CD8, CD45R, Macrophage, Neutrophil, and Dentritic cell et. al. Azide Free & Low Endotoxin Monoclonal Antibody for in vivo and in vitro functional studies Rat anti mouse: CD3, CD4, CD8a, CD11a, CD11b, CD16/32, CD18, CD25, CD40, CD44, CD45RB, CD54 (ICAM1),
CD62L (L-Selectin), CD70, CD86 (B7-2), CD103, CD106 (VCAM1), CD119 (INF gamma Receptor alpha chain),
CD122 (IL-2R beta chain), CD127 (IL-7R alpha chain), CD134 (OX-40), CD252 (OX40 Ligand), CD275 (B7-RP1),
LPAM-1 (Integrin alpha4-beta7), MAdCAM-1, IL-2, CD25 (IL-2R alpha), IL-4, IL-6, CD126 (IL-6R alpha chain),
IL-10, CD210 (IL-10R), IL-12, Interferon gamma, TNF alpha, ICOS (CD278), Integrin beta-7, GITR, Thy-1.2,
VLA-4 (CD49d), Gr-1 (Ly-6G), 33D1 (a dendritic cell marker), B7-H1 (PD-L1), TCR beta chain, CD205
(a dendritic cell marker), MHC class II, 4-1BBL (CDw137L), B7-DC (PD-L2, CD273) et al. Hamster anti mouse: CD3e, CD11c, CD28, CD154 (CD40L), CD80 (B7-1), CD152 (CTLA-4), CD279 (PD-1), CD314
(NKG2D), TCR (delta/gamma), et al. One step WB/IHC/ELISA antibodies for Tags and Internal loading control molecules HRP-conjugated Anti-Tag molecules: AU1, Myc, His, HA, GST, and V5 et. al. HRP-conjugated Anti-Internal Loading Control molecules: Beta-tubulin, beta-actin, and GAPDH |
|
||||||||||||||||
|
||||||||||||||||
|
||||||||||||||||